Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Trijardy xr empagliflozin linagliptin metformin fda approval date 2020?

See the DrugPatentWatch profile for Trijardy

What FDA date did Trijardy XR get approved in 2020?

Trijardy XR (empagliflozin/linagliptin/metformin) was FDA-approved on September 18, 2020 [1].

What is Trijardy XR (and what drugs does it combine)?

Trijardy XR is a fixed-dose combination tablet that contains empagliflozin, linagliptin, and metformin [1].

Where can I verify the exact FDA approval date?

You can confirm the approval date in the FDA’s drug-approval record for Trijardy XR on Drugs@FDA [1].

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212854



Other Questions About Trijardy :

Trijardy xr? Trijardy xr manufacturer coupon? Trijardy xr price? Trijardy xr coupon? Trijardy xr cost? Trijardy coupon? Trijardy xr generic?